期刊文献+

慢性病贫血的发病机制及诊断 被引量:6

The mechanism and diagnosis of anemia of chronic disease
下载PDF
导出
摘要 慢性病贫血(ACD)是一种常见的临床并发症,可加剧原发疾病对身体的损伤,对原发疾病的治疗及预后带来不利影响。其发病机制包括促红细胞生成素(EPO)反应迟钝及红细胞寿命缩短、细胞网状内皮系统铁的摄取和滞留增加、红系祖细胞增殖受损及铁调素的负性铁调节作用。ACD的诊断主要是寻找原发疾病。其鉴别诊断主要依靠临床表现及实验室检查,除了骨髓铁染色,血清可溶性转铁蛋白受体(sTFR)及sTIR与血清铁蛋白对数的比值(sTFR/logSF)、红细胞指数、铁调素、生长转化因子(GDF)15可协助鉴别。 Anemia of chronic disease (ACD) is a common complication which can aggregate the injuries caused by primary diseases and result in negative effects on the treatment and prognosis of the primary diseases. Its mechanisms are complicated, including EPO delayed reaction and shortened life of red blood ceils, increased intake and detention of iron in the reticular system, and the productive impairment of progenitor red blood cell progenitors and negative regulation of hepcidin. The diagnosis of ACD depends on determination of primary diseases and the differential diagnosis depends on clinical manifestation and experiment tests. In addition to bone marrow iron staining, serum soluble transferrin receptor ( sTfR), the ratio of sTfR and log serum ferritin ( sTFR/log SF) , erythrocyte indices, hepcidin, transforming growth fac- tor- 15 (TGF- 15) can be useful for identification.
出处 《徐州医学院学报》 CAS 2016年第8期557-560,共4页 Acta Academiae Medicinae Xuzhou
基金 上海闵行区卫生和计划生育委员会科研课题(2013MW14) 上海市第五人民医院院级课题(2013WYYJ01)
关键词 慢性病贫血 铁调素 发病机制 诊断 anemia of chronic disease hepcidin pathological mechanism diagnosis
  • 相关文献

参考文献23

  • 1Sharma S, Nemeth E, Chen YH, et al. Involvement of hepcidin in the anemia of multiple myeloma [ J ]. Clin Cancer Res, 2008, 14 ( 11 ) :3262 - 3267.
  • 2Roy CN, Andrews NC. Anemia of inflammation : the hepcidin link [J]. Curr Opin Hematol, 2005,12(2) :107 -111.
  • 3Jurado RL. Iron, infections, and anemia of inflammation [ J ]. Clin Infect Dis, 1997,25 (4) :888 - 895.
  • 4Nemeth E. Iron regulation and erythropoiesis [ J]. Curr Opin He- matol, 2008,15(3) : 169 -175.
  • 5Bergamaschi G, Markopoulos K, Albertini R, et al. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease [ J ]. Haematologica, 2008,93 (12) : 1785 - 1791.
  • 6Spivak JL. Iron and the anemia of chronic disease [ J ]. Oncology ( Williston Park), 2002,16 ( 9 Suppl 10 ) : 25 - 33.
  • 7Mitlyng BL, Singh JA, Fume JK, et al. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases [ J]. Am J Hematol, 2006,81 (6) :432 - 438.
  • 8Ganz T, Nemeth E. Hepcidin and iron homeostasis [J]. Biochim Biophys Acta, 2012,1823 ( 9 ) : 1434 - 1443.
  • 9Pinto JP, Ribeiro S, Pontes H, et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/Ebp[J]. Blood, 2008,111 (12) :5727 - 5733.
  • 10Maciejewski JP, Selleri C, Sato T, et al. Nitric oxide suppres- sion of human hematopoiesis in vitro. Contribution to inhibitory action of interferon -',/and tumor necrosis factor-ct [ J]. J Clin Invest, 1995,96(2) : 1085 - 1092.

二级参考文献25

  • 1Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett, 2000, 480 : 147 - 150.
  • 2Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem, 2001, 276 : 7806-7810.
  • 3Qian ZM, Li HY, Sun HZ, et al. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev, 2002, 54 : 561 -587.
  • 4Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 2003, 102 :783 -788.
  • 5Knutson M, Wessling-Resniek M. Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol, 2003,38 : 61 -88.
  • 6Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liverspecific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem, 2001, 276 : 7811 -7819.
  • 7Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. PNAS, 2001,98 : 8780- 8785.
  • 8Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues?Blood Cells Mol Dis, 2003, 30 : 288 -297.
  • 9Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. PNAS, 2001, 98 : 8160-8162.
  • 10Nemeth E, Tutfle MS, Powelson J, et al. Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science, 2004, 306 : 2090- 2093.

共引文献24

同被引文献73

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部